GlassScriptPhysician profile
David J Ramsey
NPI 1881861789
$11,967.99
in general payments reported to CMS, 2019-2025
16 companies · $4,416 in 2025
The $4,416 reported for 2025 was more than what 93% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2021: $12.74 · 2022: $680 · 2023: $550 · 2024: $5,880 · 2025: $4,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,610 · Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,610.00 |
| Food and Beverage | $1,236.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $8,460.00 | 2024-2025 | Eylea |
| Beaver-Visitec International, INC. | $1,650.00 | 2022-2024 | |
| Genentech USA, INC. | $395.10 | 2022-2024 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $384.21 | 2019-2025 | Eylea Hd |
| Astellas Pharma US INC | $217.06 | 2023-2025 | Izervay |
| Alimera Sciences, INC. | $162.48 | 2023-2024 | Iluvien, Yutiq |
| Cardinal Health 110 LLC | $150.00 | 2024 | |
| Alcon Vision LLC | $149.86 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.48 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $87.50 | 2023 | Syfovre |
| Optos, INC. | $48.79 | 2019 | |
| Ani Pharmaceuticals, INC. | $47.38 | 2024-2025 | Purified Cortrophin Gel, Yutiq |
| Abbvie INC. | $33.33 | 2025 | |
| Coherus Oncology, INC. | $21.73 | 2023 | |
| Oyster Point Pharma, INC. | $21.69 | 2023 | Tyrvaya |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $17.38 | 2025 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.